Patents by Inventor Hideki Kosono

Hideki Kosono has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Acylsulfonamide derivatives
    Patent number: 6812252
    Abstract: The present invention provides new acylsulfonamide derivatives such as 4-(3-trifluoromethyl)phenylethynyl-N-(2-(5-ketohexanoylamino)sulfonylphenyl)benzamide, 4-(3-trifluoromethyl)phenylethynyl-N-(2-(2-propyloxyacetylamino)sulfonylphenyl)benzamide or analogues thereof. These acylsulfonamide derivatives have a hypoglycemic effect equal to or superior to the effects of the conventional hypoglycemic agents and they are free from the side effects unlike the glitazone compounds.
    Type: Grant
    Filed: January 3, 2003
    Date of Patent: November 2, 2004
    Assignee: Ajinomoto Co., Inc.
    Inventors: Hiroshi Ikawa, Masato Nishimura, Keiji Okada, Takashi Nakamura, Kazuhiro Kojima, Hideki Kosono
  • Hypoglycemic agent
    Publication number: 20030191323
    Abstract: The present invention provides a hypoglycemic agent containing an acylsulfonamide derivative such as a compound of the following formula or an analog thereof, which agent is usable for preventing and curing diabetes: 1
    Type: Application
    Filed: January 2, 2003
    Publication date: October 9, 2003
    Applicant: Ajinomoto Co., Inc.
    Inventors: Hiroshi Ikawa, Masato Nishimura, Keiji Okada, Takashi Nakamura, Niro Inaba, Kazuhiro Kojima, Hideki Kosono
  • Acylsulfonamide derivatives
    Publication number: 20030181764
    Abstract: The present invention provides new acylsulfonamide derivatives such as 4-(3-trifluoromethyl)phenylethynyl-N-(2-(5-ketohexanoylamino)sulfonylphenyl)benzamide, 4-(3-trifluoromethyl)phenylethynyl-N-(2-(2-propyloxyacetylamino)sulfonylphenyl)benzamide or analogues thereof. These acylsulfonamide derivatives have a hypoglycemic effect equal to or superior to the effects of the conventional hypoglycemic agents and they are free from the side effects unlike the glitazone compounds.
    Type: Application
    Filed: January 3, 2003
    Publication date: September 25, 2003
    Applicant: AJINOMOTO CO. INC
    Inventors: Hiroshi Ikawa, Masato Nishimura, Keiji Okada, Takashi Nakamura, Kazuhiro Kojima, Hideki Kosono